These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


105 related items for PubMed ID: 6084083

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Leukemia and pre-DIC--coagulation and fibrinolytic parameters in severe infection at the nadir of leukocyte after chemotherapy].
    Saito M, Asakura H, Jokaji H, Uotani C, Kumabashiri I, Morishita E, Yamazaki M, Matsuda T.
    Rinsho Byori; 1990 Jul; Suppl 86():158-63. PubMed ID: 2232237
    [No Abstract] [Full Text] [Related]

  • 3. [Disseminated intravascular coagulation as a complication of shock].
    Bottari M, Donati L, Gagnatelli G.
    Atti Accad Med Lomb; 1973 Jul; 28(1-4):5-8. PubMed ID: 4549785
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Antithrombin III in the treatment of disseminated intravascular coagulation].
    Nordgaard-Andersen I, Madsen JR.
    Ugeskr Laeger; 1997 Feb 03; 159(6):730-1. PubMed ID: 9045459
    [No Abstract] [Full Text] [Related]

  • 7. Plasma alpha2-plasmin inhibitor levels in patients with leukemia.
    Kageyama T, Oyabu H, Dohi T, Matsumoto K, Tsumoto S.
    Bull Osaka Med Sch; 1983 Jul 03; 29(1):36-42. PubMed ID: 6589023
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antithrombin III and sepsis.
    Mammen EF.
    Intensive Care Med; 1998 Jul 03; 24(7):649-50. PubMed ID: 9722032
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Plasma level of activated factor IX-antithrombin III complex in hypercoagulable state].
    Sugiura I, Takahashi I, Kagami K, Takamatsu J.
    Rinsho Byori; 1990 Jul 03; Suppl 86():149-57. PubMed ID: 2232236
    [No Abstract] [Full Text] [Related]

  • 15. [Evidence-based medicine and disseminated intravascular coagulation (DIC)].
    Skadborg MK.
    Ugeskr Laeger; 1997 May 19; 159(21):3189-90. PubMed ID: 9199010
    [No Abstract] [Full Text] [Related]

  • 16. Differences between functional and immunologic determinations of plasma antithrombin during the treatment of disseminated intravascular coagulation by infusion of antithrombin III concentrate.
    Jespersen J, Rasmussen NR, Sidelmann J.
    Acta Chir Scand Suppl; 1982 May 19; 509():105-7. PubMed ID: 6962611
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.